$KANT
KINETA, INC./DE

2018 Q2 Form 10-Q Financial Statement

#000156459018020479 Filed on August 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $843.0K $1.147M
YoY Change -26.5% -20.95%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.960M $2.900M
YoY Change 36.55% -7.05%
% of Gross Profit
Research & Development $12.60M $15.37M
YoY Change -18.0% 107.59%
% of Gross Profit
Depreciation & Amortization $530.0K $340.0K
YoY Change 55.88% 385.71%
% of Gross Profit
Operating Expenses $16.56M $18.27M
YoY Change -9.36% 73.7%
Operating Profit -$15.72M -$17.13M
YoY Change -8.22% 88.85%
Interest Expense $190.0K $170.0K
YoY Change 11.76% 750.0%
% of Operating Profit
Other Income/Expense, Net $46.00K -$2.000K
YoY Change -2400.0% -60.0%
Pretax Income -$15.48M -$16.96M
YoY Change -8.73% 87.4%
Income Tax
% Of Pretax Income
Net Earnings -$15.48M -$16.96M
YoY Change -8.73% 87.32%
Net Earnings / Revenue -1836.06% -1478.47%
Basic Earnings Per Share
Diluted Earnings Per Share -$8.600M -$13.57M
COMMON SHARES
Basic Shares Outstanding 36.01M 25.04M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.80M $57.70M
YoY Change 5.37% 35.45%
Cash & Equivalents $20.76M $23.90M
Short-Term Investments $40.90M $33.80M
Other Short-Term Assets $2.100M $3.100M
YoY Change -32.26% 177.03%
Inventory
Prepaid Expenses
Receivables $700.0K
Other Receivables $0.00
Total Short-Term Assets $62.96M $61.50M
YoY Change 2.37% 40.09%
LONG-TERM ASSETS
Property, Plant & Equipment $15.50M $500.0K
YoY Change 3000.0% 9.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.000M $100.0K
YoY Change 900.0% -1.96%
Total Long-Term Assets $16.54M $600.0K
YoY Change 2657.0% -29.58%
TOTAL ASSETS
Total Short-Term Assets $62.96M $61.50M
Total Long-Term Assets $16.54M $600.0K
Total Assets $79.50M $62.10M
YoY Change 28.02% 38.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.900M $2.300M
YoY Change -17.39% -38.52%
Accrued Expenses $7.500M $6.100M
YoY Change 22.95% 99.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.400M $10.90M
YoY Change -13.76% -3.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.70M $0.00
YoY Change -100.0%
Total Long-Term Liabilities $13.70M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.400M $10.90M
Total Long-Term Liabilities $13.70M $0.00
Total Liabilities $23.10M $10.90M
YoY Change 111.89% -22.9%
SHAREHOLDERS EQUITY
Retained Earnings -$189.5M
YoY Change 38.06%
Common Stock $26.00K
YoY Change 30.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $56.33M $51.16M
YoY Change
Total Liabilities & Shareholders Equity $79.50M $62.06M
YoY Change 28.11% 38.67%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$15.48M -$16.96M
YoY Change -8.73% 87.32%
Depreciation, Depletion And Amortization $530.0K $340.0K
YoY Change 55.88% 385.71%
Cash From Operating Activities -$12.84M -$12.34M
YoY Change 4.05% 81.2%
INVESTING ACTIVITIES
Capital Expenditures -$410.0K -$100.0K
YoY Change 310.0% 900.0%
Acquisitions
YoY Change
Other Investing Activities $3.080M $20.92M
YoY Change -85.28% 209100.0%
Cash From Investing Activities $2.670M $20.83M
YoY Change -87.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.34M 20.00K
YoY Change 51600.0% -105.71%
NET CHANGE
Cash From Operating Activities -12.84M -12.34M
Cash From Investing Activities 2.670M 20.83M
Cash From Financing Activities 10.34M 20.00K
Net Change In Cash 170.0K 8.510M
YoY Change -98.0% -218.85%
FREE CASH FLOW
Cash From Operating Activities -$12.84M -$12.34M
Capital Expenditures -$410.0K -$100.0K
Free Cash Flow -$12.43M -$12.24M
YoY Change 1.55% 80.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2138000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
62958000
CY2018Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14772000
CY2018Q2 pti Deferred Offering Costs Noncurrent
DeferredOfferingCostsNoncurrent
196000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1108000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
16000
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11000
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25040131
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15462000
us-gaap Profit Loss
ProfitLoss
-26504000
us-gaap Profit Loss
ProfitLoss
-32054000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1094000
pti Premium Discount On Short Term Investments
PremiumDiscountOnShortTermInvestments
129000
pti Premium Discount On Short Term Investments
PremiumDiscountOnShortTermInvestments
-37000
us-gaap Share Based Compensation
ShareBasedCompensation
1841000
us-gaap Share Based Compensation
ShareBasedCompensation
1353000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
534000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
382000
pti Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-22000
pti Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-73000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-41000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
62000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
761000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1292000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-18000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-18000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-258000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
289000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
402000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1817000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-729000
pti Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1118000
pti Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-636000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24865000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27691000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
24883000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
18730000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
28850000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3561000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
32977000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10388000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10916000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5310000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31674000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18907000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20758000
pti Deferred Offering Costs Included In Accounts Payable
DeferredOfferingCostsIncludedInAccountsPayable
25000
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Summary of Significant Accounting Policies<font style="font-weight:normal;font-style:normal;">&nbsp;&nbsp;</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s significant accounting policies, which are disclosed in the audited consolidated financial statements for the year ended December 31, 2017 and the notes thereto are included in the Company&#8217;s Annual Report on Form 10-K that was filed with the SEC on March 14, 2018. Certain amounts reported in the previous year have been recast as a result of the retrospective adoption of new accounting standards in the first quarter of 2018. Refer to Note 2 - <font style="font-style:italic;">Recently Issued and Adopted Accounting Pronouncements, </font>Note 8 - <font style="font-style:italic;">Collaboration Agreement</font>, and Note 11 - <font style="font-style:italic;">Leases, </font>for further discussion.&nbsp;&nbsp;</p></div>
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, revenue recognition, the accrual for research and development expenses and the valuation of common stock, and the derivative liability. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.</p></div>
CY2017Q2 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2018Q2 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-22000
CY2018Q2 pti Prepaid Clinical Manufacturing And Scientific Expenses Current
PrepaidClinicalManufacturingAndScientificExpensesCurrent
425000
CY2018Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3748000
CY2018Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
14745000
CY2018Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
60800000
CY2018Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2018Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2018Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
40890000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2018Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2017Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
pti Fair Value Option Methodology And Assumption
FairValueOptionMethodologyAndAssumption
Monte-Carlo simulation analysis
CY2017Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0406
CY2017Q4 pti Prepaid Clinical Manufacturing And Scientific Expenses Current
PrepaidClinicalManufacturingAndScientificExpensesCurrent
568000
CY2018Q2 us-gaap Prepaid Insurance
PrepaidInsurance
1035000
CY2017Q4 us-gaap Prepaid Insurance
PrepaidInsurance
55000
CY2018Q2 pti Other Prepaid Expenses And Other Current Assets
OtherPrepaidExpensesAndOtherCurrentAssets
678000
CY2017Q4 pti Other Prepaid Expenses And Other Current Assets
OtherPrepaidExpensesAndOtherCurrentAssets
754000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1704000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1542000
CY2018Q2 pti Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
4227000
CY2017Q4 pti Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
3930000
CY2018Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
283000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
556000
CY2018Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
308000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
92000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1153000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
991000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2375000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1735000
us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2017Q2 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36009109
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25040131
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35245796
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25030291
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3530135
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2590558
pti Lessee Leasing Arrangements Operating Lease Expiration Date
LesseeLeasingArrangementsOperatingLeaseExpirationDate
2018-05
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P7Y
CY2018Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
662000
CY2017Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
286000
CY2018Q2 us-gaap Variable Lease Cost
VariableLeaseCost
260000
CY2018Q2 us-gaap Lease Cost
LeaseCost
402000
CY2017Q2 us-gaap Lease Cost
LeaseCost
286000
us-gaap Operating Lease Cost
OperatingLeaseCost
1322000
us-gaap Operating Lease Cost
OperatingLeaseCost
572000
us-gaap Variable Lease Cost
VariableLeaseCost
260000
us-gaap Lease Cost
LeaseCost
1062000
us-gaap Lease Cost
LeaseCost
572000
us-gaap Operating Lease Payments
OperatingLeasePayments
461000
us-gaap Operating Lease Payments
OperatingLeasePayments
668000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
14746000
CY2018Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M2D
CY2017Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10M2D
CY2018Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0450
CY2018Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
828000
CY2018Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1686000
CY2018Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1733000
CY2018Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1780000
CY2018Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1829000
CY2018Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
10637000
CY2018Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18493000

Files In Submission

Name View Source Status
0001564590-18-020479-index-headers.html Edgar Link pending
0001564590-18-020479-index.html Edgar Link pending
0001564590-18-020479.txt Edgar Link pending
0001564590-18-020479-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
godpuyg3u5oa000001.jpg Edgar Link pending
godpuyg3u5oa000002.jpg Edgar Link pending
godpuyg3u5oa000003.jpg Edgar Link pending
godpuyg3u5oa000004.jpg Edgar Link pending
gvp45sznrzsy000001.jpg Edgar Link pending
gwjliof3o2tu000001.jpg Edgar Link pending
pti-10q_20180630.htm Edgar Link pending
pti-20180630.xml Edgar Link completed
pti-20180630.xsd Edgar Link pending
pti-20180630_cal.xml Edgar Link unprocessable
pti-20180630_def.xml Edgar Link unprocessable
pti-20180630_lab.xml Edgar Link unprocessable
pti-20180630_pre.xml Edgar Link unprocessable
pti-ex101_43.htm Edgar Link pending
pti-ex102_41.htm Edgar Link pending
pti-ex103_42.htm Edgar Link pending
pti-ex104_89.htm Edgar Link pending
pti-ex105_536.htm Edgar Link pending
pti-ex311_8.htm Edgar Link pending
pti-ex312_6.htm Edgar Link pending
pti-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending